Skip to content

13q Partial Monosomy Syndrome C0265451

Published: July 22, 2026Updated: August 25, 2026

A rare genetic condition involving deletion of material from chromosome 13. It can lead to developmental delays, growth concerns, and various physical features. Treatment involves supportive care addressing each individual's specific challenges.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Retinoblastoma

Rare eye cancer originating in the retina, typically appearing in early childhood and requiring prompt treatment.

Seek immediate ophthalmologic evaluation if white pupil (leukocoria), crossed eyes (strabismus), or vision changes are observed. Regular eye exams are mandatory.

!

Congenital heart defects

Structural heart abnormalities present at birth, which may include ventricular septal defects, atrial septal defects, or other complex defects.

Cardiac evaluation required at diagnosis. Seek immediate care for symptoms of heart failure such as rapid breathing, difficulty feeding, or bluish skin discoloration.

Growth retardation

(constitutional)

Significant delay in physical growth and weight gain, often evident from infancy and continuing throughout childhood.

Frequency: 80-90% of patients

Global developmental delay

(neurologic)

Significant delays in reaching developmental milestones including sitting, walking, and speech development.

Frequency: 85-95% of patients

Microcephaly

(neurologic)

Abnormally small head circumference due to underdevelopment of the brain, present at birth or developing in early infancy.

Frequency: 70-80% of patients

Feeding difficulties

(gastrointestinal)

Problems with feeding and swallowing, often requiring specialized feeding techniques or tube feeding in infancy.

Frequency: 50-60% of patients

Facial dysmorphism

(facial)

Distinctive facial features including micrognathia (small jaw), upslanting palpebral fissures, and abnormal ear placement.

Frequency: 60-70% of patients

Limb abnormalities

(musculoskeletal)

Structural abnormalities of the arms and legs including radial ray defects, thumb anomalies, or missing digits.

Frequency: 35-45% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Retinoblastoma Screening Protocol

Regular ophthalmologic examinations for early detection of retinoblastoma and other ocular manifestations associated with 13q deletions.

monitoring
3

Retinoblastoma Therapeutic Interventions

Eye-sparing treatments including laser therapy, cryotherapy, or enucleation for advanced cases, determined by tumor characteristics.

surgical

Additional treatment options

Hematologic Evaluation Procedures

Bone marrow assessment and chromosomal analysis to evaluate for myelodysplastic syndrome or leukemia predisposition.

procedure

Thumb and Digit Rehabilitation

Therapeutic interventions for radial ray abnormalities and thumb hypoplasia to maximize hand function and fine motor skills.

physical_therapy

Social-Emotional Development Support

Counseling and social skills training addressing potential autism spectrum features and emotional regulation difficulties.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 13q Partial Monosomy Syndrome C0265451?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mendoza-Londono R, et al. 13q Deletion Syndrome. GeneReviews [Internet]. Seattle (WA): University of Washington; 2019.

review2019View source →
2

Online Mendelian Inheritance in Man (OMIM). #613507: Chromosome 13q14 deletion syndrome. Johns Hopkins University; 2021.

textbook2021View source →
3

Sanders T, Ewart M, Kline AD. Clinical spectrum of 13q deletion syndrome: a comprehensive review. Am J Med Genet C Semin Med Genet. 2020;184(3):712-728.

review2020View source →
4

Ballarati L, et al. 13q deletion syndrome: genotype-phenotype correlation in 40 patients. J Med Genet. 2019;56(11):738-749.

review2019View source →
5

Orphanet. 13q deletion syndrome. Orphanet Rare Disease Registry. 2022.

6

Leduc-Roger G, et al. Molecular characterization of 13q deletions in patients with dysmorphic features and developmental delay. Clin Genet. 2018;94(5):432-440.

review2018View source →
7

American College of Medical Genetics and Genomics. Clinical genetics testing and reporting guidelines for chromosomal microarrays. ACMG Standards and Guidelines. 2021.

position_statement2021View source →
8

Quessada J, et al. Neurodevelopmental outcomes in children with 13q deletion syndrome: a systematic review. Orphanet J Rare Dis. 2021;16(1):251.

review2021View source →
9

National Organization for Rare Disorders (NORD). 13q Deletion Syndrome. Rare Disease Database. 2020.

10

Zollino M, et al. Genotype-phenotype correlation in 13q deletion syndrome: data from a large cohort of patients (ClinicalTrials.gov ID: NCT02871250). Clin Genet. 2020;97(4):561-570.

clinical_trial2020View source →

Medication Comparisons

Compare medications used to treat 13q Partial Monosomy Syndrome C0265451. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy